NEWS
ResMed’s 12.5 per cent fall a drag on entire ASX
MELBOURNE: Large-cap healthcare stock ResMed’s 12.5 per cent fall to $27.97 in afternoon ... read more
Failed resort developer Mawhinney gets mixed retrial news
MELBOURNE: The Federal Court has blocked James Mawhinney from scrapping key claims from ... read more